PURPOSE: To examine the possible link of acute-onset glaucoma with topiramate. DESIGN:
Case-control study. METHODS: A case-control study was conducted among a cohort of …

PURPOSE: To investigate the risk of glaucoma development after being prescribed
topiramate. DESIGN: A retrospective, population-based cohort study using an administrative …

Purpose: The aim of this article is to create awareness among medical colleagues regarding
the severe ophthalmic side effects associated with topiramate use. Methods: A case of …

Occasional reports of uveitis following topiramate use necessitated an investigation of
relevant cases from safety databases and published biomedical literature. Data mining of …

PURPOSE: To evaluate spontaneous reports of ocular side effects associated with
topiramate use. DESIGN: Retrospective case series. METHODS: One hundred fifteen case …

Objective: Describe bilateral acute onset myopia and angle-closure glaucoma as ocular
adverse effects of topiramate. Case Report: A 23 year-old woman developed bilateral …

Purpose: To determine the changes in refractive error, and the cornea, anterior chamber,
and retina induced by topiramate. Methods: The study included 76 eyes of 38 patients that …

ary acute angle-closure glaucoma associated with topiramate (Topamax; Ortho-McNeil
Pharmaceutical, Inc, Raritan, NJ) and submitted to the Food and Drug Administration's …

Topiramate (TPM) is a sulfonamide drug with multiple modes of action. It inhibits carbonic
anhydrase, blocks sodium channels, enhances potassium channels, and stimulates …

Purpose. The purpose of this report is to describe acute myopia as an ocular adverse
reaction to topiramate (Topamax, Ortho-McNeil, Raritan, NJ) and discuss the importance of …